Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
2
×
boston top stories
clinical trials
deals
fda
life sciences
national blog main
national top stories
roche
2
×
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
blueprint medicines
boehringer ingelheim
cstone pharmaceuticals
dicerna pharamceuticals
eli lilly
european medicines agency
fisogatinib
flatiron health
genentech
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
jeff albers
medullary thyroid cancer
non-small cell lung cancer
patisiran
pralsetinib
rna interference
san francisco blog main
san francisco top stories
selpercatinib
thermo fisher scientific
thyroid cancer
world health organization
What
drug
medicines
roche
team
2
×
approval
blueprint
cancer
candidate
caught
causing
currently
dicerna
disease
eye
fda
gene
hepatitis
intended
marketing
muscle
pact
pay
pharma
pharmaceuticals
producing
protein
regulatory
research
ret
review
stop
wins
Language
unset
2
×
Current search:
roche
×
unset
×
" boston blog main "
×
boston
×
team
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug